Literature DB >> 3003047

Isolation and characterization of a Chinese hamster ovary cell line requiring ethanolamine or phosphatidylserine for growth and exhibiting defective phosphatidylserine synthase activity.

D R Voelker, J L Frazier.   

Abstract

A mutant cell line (designated M.9.1.1) requiring ethanolamine for growth was derived from Chinese hamster ovary (CHO-K1) cells using 5-bromodeoxyuridine enrichment. The ethanolamine requirement was readily replaced by 20 microM phosphatidylserine and 10 microM lysophosphatidylethanolamine. When M.9.1.1 cells were supplemented with phosphatidyl[3H]serine it was rapidly taken up, and subsequently decarboxylated to form phosphatidyl[3H]ethanolamine. The incorporation of [3H]serine into phosphatidylserine in the mutant cells was 57% of that in the parental cells. Phosphatidylethanolamine synthesis from [3H]serine in the mutant cells was 35% of that in parental cells. When M.9.1.1 cells were deprived of ethanolamine for 48 h the level of phosphatidylserine decreased 34% and the level of phosphatidylethanolamine decreased 26% compared to parental cells. At the same time the rate of turnover of phosphatidylserine was reduced to half that found in parental cells. Examination of the enzymes of phosphatidylserine metabolism indicated defective phosphatidylserine synthase activity in the mutant. When exogenous phosphatidylcholine was used as the phospholipid substrate for the reaction the apparent kinetic constants were Vmax (mutant) = 5.7 pmol/min/mg protein and Vmax (parental) = 17.5 pmol/min/mg protein. Measurement of the back reaction (ATP-independent incorporation of choline into phospholipid) gave no detectable activity in the mutant cells. The data indicate that the phosphatidylcholine-dependent synthesis of phosphatidylserine is the primary lesion in M.9.1.1.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3003047

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  26 in total

Review 1.  Lipid transport pathways in mammalian cells.

Authors:  D R Voelker
Journal:  Experientia       Date:  1990-06-15

Review 2.  Phosphatidylserine in the brain: metabolism and function.

Authors:  Hee-Yong Kim; Bill X Huang; Arthur A Spector
Journal:  Prog Lipid Res       Date:  2014-06-30       Impact factor: 16.195

3.  Phospholipid metabolism of serine in Plasmodium-infected erythrocytes involves phosphatidylserine and direct serine decarboxylation.

Authors:  N Elabbadi; M L Ancelin; H J Vial
Journal:  Biochem J       Date:  1997-06-01       Impact factor: 3.857

4.  Post-translational processing of the phosphatidylserine decarboxylase gene product in Chinese hamster ovary cells.

Authors:  O Kuge; K Saito; M Kojima; Y Akamatsu; M Nishijima
Journal:  Biochem J       Date:  1996-10-01       Impact factor: 3.857

5.  Physiological consequences of disruption of mammalian phospholipid biosynthetic genes.

Authors:  Dennis E Vance; Jean E Vance
Journal:  J Lipid Res       Date:  2008-10-27       Impact factor: 5.922

6.  Isolation of novel animal cell lines defective in glycerolipid biosynthesis reveals mutations in glucose-6-phosphate isomerase.

Authors:  Jorge F Haller; Conor Smith; Dailan Liu; Hongying Zheng; Keith Tornheim; Gil-Soo Han; George M Carman; Raphael A Zoeller
Journal:  J Biol Chem       Date:  2009-11-10       Impact factor: 5.157

7.  Phospholipid composition in spinal cord regions after ischemia/reperfusion.

Authors:  N Lukácová; P Jalc; J Marsala
Journal:  Neurochem Res       Date:  1998-08       Impact factor: 3.996

8.  The ethanolamine requirement of keratinocytes for growth is not due to defective synthesis of ethanolamine phosphoacylglycerols by the decarboxylation pathway.

Authors:  G Arthur; X Lu
Journal:  Biochem J       Date:  1993-07-01       Impact factor: 3.857

9.  Phosphatidylserine synthase 2: high efficiency for synthesizing phosphatidylserine containing docosahexaenoic acid.

Authors:  Atsuko Kakio Kimura; Hee-Yong Kim
Journal:  J Lipid Res       Date:  2012-10-15       Impact factor: 5.922

10.  The development of a metabolic disease phenotype in CTP:phosphoethanolamine cytidylyltransferase-deficient mice.

Authors:  Morgan D Fullerton; Fatima Hakimuddin; Arend Bonen; Marica Bakovic
Journal:  J Biol Chem       Date:  2009-07-22       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.